Amanda Bogle, a healthcare attorney at Sheppard Mullin, discusses the evolving regulatory landscape for pharmacies, stressing ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN) are two diseases that have a ...

An expert discusses how home administration of oncology drugs in the US faces significant logistical and reimbursement ...

Company officials say they are focusing on "more disciplined managed products" as they prepare to exit PPOs in 2026 that currently cover 800,000 members, including 600,000 people enrolled in Medicare ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The Joint Commission revamps pediatric care standards, prioritizing children's unique healthcare needs for safer, more effective hospital experiences.

Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the ...

Sarepta continues to work with regulators to complete the safety label update for Elevidys, and they are discussing an approach for risk mitigation for non-ambulatory patients.

Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to ...

An expert discusses how real-world evidence is driving gene therapy adoption in BCG-unresponsive disease primarily through ...

Health policy researcher Geoffrey Joyce argues that only delinking compensation from the list price of a drug will lower drug ...